No abstract available
MeSH terms
-
Animals
-
Annexin A5 / metabolism
-
Annexin A5 / pharmacology*
-
Annexin A5 / therapeutic use
-
Chemokine CXCL2
-
Chemokines / metabolism
-
Cytoprotection / drug effects
-
Dimerization
-
Disease Models, Animal
-
Down-Regulation
-
Endothelial Cells / drug effects*
-
Endothelial Cells / metabolism
-
Endothelial Cells / pathology
-
Hepatitis / etiology
-
Hepatitis / metabolism
-
Hepatitis / pathology
-
Hepatitis / physiopathology
-
Hepatitis / prevention & control*
-
Intercellular Adhesion Molecule-1 / metabolism
-
Ischemia / complications*
-
Ischemia / drug therapy
-
Ischemia / metabolism
-
Ischemia / pathology
-
Ischemia / physiopathology
-
Liver / blood supply
-
Liver / drug effects*
-
Liver / metabolism
-
Liver / pathology
-
Liver / physiopathology
-
Liver Circulation / drug effects
-
Mice
-
Microcirculation / drug effects
-
Necrosis
-
Phosphatidylserines / metabolism*
-
Protective Agents / metabolism
-
Protective Agents / pharmacology*
-
Protective Agents / therapeutic use
-
Recombinant Proteins / pharmacology
-
Reperfusion Injury / etiology
-
Reperfusion Injury / metabolism
-
Reperfusion Injury / pathology
-
Reperfusion Injury / physiopathology
-
Reperfusion Injury / prevention & control*
-
Vascular Cell Adhesion Molecule-1 / metabolism
Substances
-
Annexin A5
-
Chemokine CXCL2
-
Chemokines
-
Cxcl2 protein, mouse
-
Phosphatidylserines
-
Protective Agents
-
Recombinant Proteins
-
Vascular Cell Adhesion Molecule-1
-
diannexin, human
-
Intercellular Adhesion Molecule-1